MTOR and cervical carcinoma: In addition, in cervical cancer (CC) studies, the downregulation of Derlin1 affects the activation of the AKT/mTOR signaling pathway, and the absence of Derlin1 can inhibit the expression of p-AKT and p-mTOR [29].